TouchNEUROLOGY discusses the impact of COVID-19 on long-term cognitive dysfunction and acceleration of Alzheimer symptoms with Gabriel de Erausquin

17/11/2021

TouchNEUROLOGY interviewed Gabriel de Erausquin (UT Health San Antonio, Texas, USA), during the 2021 edition of the Alzheimer’s Association International Conference (AAIC21) earlier this year. Their discussion was around the Alzheimer’s Association-led Global SARS-CoV-2 Consortium and the links between long-term cognitive dysfunction, acceleration of Alzheimer’s disease (AD) symptoms and COVID-19. The interview is available to view online:

Gabriel A de Erausquin, AAIC 2021: The Alzheimer's Association-led Global SARS-CoV-2 Consortium - touchNEUROLOGY